Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00799084 · ClinicalTrials.gov registry record · Phase 2
Automated Telephone Monitoring for Symptom Management
A Phase 2 study, sponsored by Michigan State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 526
- Enrollment target
NCT00799084 is a Phase 2 study that has completed, run by Michigan State University. The registered enrollment target is 526 participants.
The verdict
NCT00799084, a Phase 2 study, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 526 participants
- Enrollment target
Study Summary
To improve the management of symptoms, patients with cancer undergoing chemotherapy will be monitored using an automated telephone system to record the severity of 15 prevalent symptoms for up to 8 consecutive weeks. Outcomes include; significant reduction in symptom severity and improvement in health states.
Interventions
- BEHAVIORAL Nurse
- BEHAVIORAL AVR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 526 participants |
| Start Date | 2003-04 |
| Est. Completion | 2006-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00799084
The ClinicalTrials.gov registry entry for NCT00799084 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 526 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nurse is the first listed.
NCT00799084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00799084 about?
NCT00799084 is a clinical study titled "Automated Telephone Monitoring for Symptom Management". To improve the management of symptoms, patients with cancer undergoing chemotherapy will be monitored using an automated telephone system to record the severity of 15 prevalent symptoms for up to 8 consecutive weeks. Outcomes include; significant reduction in symptom severity and improvement in heal...
What is the current status of trial NCT00799084?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 526 participants. The study started on 2003-04. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00799084?
The interventions under investigation include: Nurse (BEHAVIORAL), AVR (BEHAVIORAL).
Who is sponsoring clinical trial NCT00799084?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.